Literature DB >> 1958849

Chemotherapy in pancreatic cancer: a rational pursuit?

J A Wils1.   

Abstract

A review on the chemotherapy in advanced pancreatic cancer is presented. Pancreatic cancer is an extremely chemotherapy resistant tumor and results of cytostatic drug treatment so far are unsatisfactory. For patients with locally advanced disease the combination of chemo- and radiotherapy may palliate some patients. To date no standard treatment is available and patients should be entered in clinical protocols assessing new treatment options.

Entities:  

Mesh：

Year:  1991        PMID： 1958849     DOI： 10.1097/00001813-199102000-00001

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN： 0959-4973            Impact factor:   2.248


  3 in total

1.  Intraaortic stop-flow infusion: pharmacokinetic feasibility study of regional chemotherapy for unresectable gastrointestinal cancers.

Authors:  A M Averbach; O A Stuart; T A Sugarbaker; A D Stephens; V Fernandez-Trigo; F Shamsa; P H Sugarbaker
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

Review 2.  Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time. The San Antonio Drug Development Team.

Authors:  D D Von Hoff; A L Goodwin; L Garcia
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

3.  Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial.

Authors:  H Bernhard; E Jäger-Arand; G Bernhard; M Heike; O Klein; J F Riemann; K H Meyer zum Büschenfelde; W Dippold; A Knuth
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.